SHUKRAPHAR Shukra Pharmaceuticals Ltd Capital Structure Changes Announcement 2024 - Rights Issue Approval Shukra Pharmaceuticals Ltd has received in-principal approval from BSE for a Rights Issue of equity shares worth at least Rs. 36 crores..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Shukra Pharmaceuticals Ltd